Blog - Page 3354 of 5747

TuesdayDec 20, 2011 12:20 pm

Biostar Pharmaceuticals (BSPM) Signs 1-Year Distribution Agreement in China

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases afflicting the Chinese population. The company announced today that its newly acquired subsidiary, Shaanxi Weinan, signed a 1-year distribution agreement with Shaanxi Huikang Pharmaceuticals Company effective January 1, 2012. Huikang Pharmaceuticals is a distributor of pharmaceutical products in 11 provinces in northwest and northern China and has a network of over 300 drugstores and hospitals. Huikang Pharmaceuticals will distribute ten Biostar products. These products include six existing products which are currently being distributed through Biostar's own network,…

TuesdayDec 20, 2011 11:54 am

BIO-key International, Inc. (BKYI) Granted U.S. Patent for Algorithmic Technique that Analyzes Characteristics of Fingerprints

BIO-key International, Inc., a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, announced that the U.S. Patent office has granted a patent for their fingerprint software algorithms that utilize directional fields to more effectively and completely process, enhance and identify fingerprints. The software determines the direction of ridges in the fingerprints thus making the segments easier to analyze for quality, create computer models from and map to detect and correct missing or incorrect information. The patent gives the company true ownership of this algorithm technology. "BIO-key is on the forefront of algorithm research and system advancement.…

TuesdayDec 20, 2011 11:12 am

QualityStocks Introduces Top 3 List of Best Investment Newsletter Recommendations

QualityStocks provides online tools and resources to connect subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer many tools to execute this mission, and now we’d like to introduce the QualityStocks Top 3 List. The Top 3 List allows investors subscribed to The QualityStocks Daily to quickly see which newsletters picked the best performing stocks of the day, saving you time and potentially money you’re missing out on. To sign up now,…

TuesdayDec 20, 2011 10:48 am

Stock Guru Featured Company: Colt Resources, Inc. (COLTF)

Colt Resources, Inc., a Canadian junior exploration company, is engaged in the acquisition, exploration and development of mineral properties with an emphasis on gold and tungsten. It is currently focused on advanced stage exploration projects in Portugal, where it is the second largest lease holder of mineral concessions. While under explored in modern times, Portugal has a long tradition of mining history and was a major source of the riches that financed the Roman Empire during its expansion. Colt has an excellent working relationship with the Portuguese Government and anticipates the development of several mines in this EU member country.…

TuesdayDec 20, 2011 9:50 am

FluoroPharma Medical, Inc. (FPMI) Raises a Collective Total of $7M in 2011

FluoroPharma Medical, Inc., a company specializing in the development of breakthrough diagnostic imaging products that utilize positron emission tomography (PET) technology to detect and assess pathology before clinical manifestation of diseases, announced this morning that they have secured an additional $1.010 million, bringing the total to more than $7 million over the course of 2011 from institutional and accredited investors. "We are excited by the opportunities this additional working capital creates for FluoroPharma to significantly accelerate development of our pipeline," stated Thijs Spoor, FluoroPharma's President and CEO. "The funding will allow us to further advance our most promising portfolio of…

MondayDec 19, 2011 5:44 pm

Xenonics Holdings, Inc. (XNNH) Reports Fiscal Results for 2011

Today, Xenonics Holdings, Inc. released their announced financial report for the fiscal year 2011, ending on September 30. The company released an overall optimistic report. Xenonics is focused on producing ultra-high intensity lighting products as well as low-light vision apparatus for military, law enforcement, public safety, and commercial customers. The company produces the NightHunter series of lighting products, which is used by every branch of the US Armed Forces. Xenonics also produces the SuperVision line of night vision apparatus, designed for commercial and military use. During their 2011 fiscal year, Xenonics' revenue increased to $7,179,000, up from $4,397,000 in 2010.…

MondayDec 19, 2011 3:04 pm

Stock Guru Featured Company: Beacon Enterprise Solutions Group, Inc. (BEAC)

Beacon Enterprise Solutions Group, Inc. specializes in designing, implementing and managing high performance Information Technology Systems ("ITS") infrastructure solutions. Offering national, multi-national and global, turnkey ITS infrastructure solutions, the company is capable of delivering professional services to Fortune 1000 and large multi-site firms as they increasingly single source and outsource to reduce costs while optimizing critical planning, design, program, project and construction management and managed services. Leveraging standardization, rapid mobilization and a just-in-time professional services approach, Beacon Enterprise Solutions serves as a single source for national, multi-national and global enterprise clients, including special practices focused on data centers, campuses, smart…

MondayDec 19, 2011 2:32 pm

SmallCapVoice Featured Company: AnyThing Technologies Media, Inc. (EXMT)

AnyThing Technologies Media, Inc. is a multi-media digital applications, production and marketing company. The company’s goal is to combine the expertise of its team members to create a cohesive force, which is to carry the company forward in the marketplace to a preeminent position through revenue sharing and acquisitions. Business development involves evaluating a business and then helping it to realize its full potential, using such tools as marketing, sales, information management and customer service. AnyThing Technologies will function as the parent company of subsidiary corporations, each with their own professional management team with extensive backgrounds in finance, manufacturing, marketing…

MondayDec 19, 2011 2:22 pm

Obscene Jeans (OBJE) Acquisition Target Initiates Development Talks for New Social Media Platform

Obscene Interactive, subsidiary of Obscene Jeans Corp., today announced that its latest acquisition target, A-Plus Technologies (A-Plus), has commenced talks with SoKap Community Networks Inc. to co-develop a new social media platform. The two companies are discussing the possibility of the development of a crowd-funding platform called Traktorbeem, which would combine social media with investor sentiment and market trend analysis to help companies raise capital. Traktorbeem would capitalize on SoKap’s crowd-funding experience and combine it with Obscene Jeans’ and A-Plus’ software and social media expertise. “SoKap’s crowdfunding platform offers tremendous synergy potential with the social media sentiment analytics software planned…

MondayDec 19, 2011 2:04 pm

Vermillion, Inc. (VRML) Purchases Correlogic Systems’ Assets for $435,000

Leading molecular diagnostics company, Vermillion, Inc., announced today that it has completed purchasing almost all of the assets associated with Correlogic Systems, Inc., the ovarian cancer diagnostics business. Before filing for bankruptcy protection under Chapter 11 in 2010, Correlogic pioneered the use of pattern recognition technologies in the development of proteomic, metabolomic and genomic-based clinical diagnostic tests. The company’s technology possessed a wide range of applications for creating disease classification models, biomarker discovery and new drug discovery processes. These initiatives led to cancer and non-cancer disease research, drug discovery, drug response monitoring, bio-security and other applications as published in 17…

Site Search

Company Search